Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Virios Therapeutics, Inc. (VIRI) had Consolidated Net Income/Loss of $-5.30M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-5.30M |
|
-- |
|
-- |
|
$5.45M |
|
$-5.45M |
|
$0.15M |
|
$-5.30M |
|
$-5.30M |
|
$-5.30M |
|
$-5.30M |
|
|
Consolidated Net Income/Loss |
$-5.30M |
$-5.30M |
|
$-5.45M |
|
$-5.45M |
|
18.78M |
|
18.78M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$4.17M |
|
-- |
|
-- |
|
$4.17M |
|
$0.36M |
|
-- |
|
-- |
|
$0.36M |
|
$3.81M |
|
$3.81M |
|
$3.81M |
|
19.26M |
|
| Cash Flow Statement Financials | |
$-4.87M |
|
-- |
|
$1.16M |
|
$7.03M |
|
$3.32M |
|
$-3.71M |
|
$0.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-139.12% |
|
-139.12% |
|
-127.14% |
|
-139.12% |
|
$0.20 |
|
$-0.26 |
|
$-0.26 |
|